Case Title Case Author 68-Year-Old Male With CAD and Recent Chest Pain and Leg Cramping Dr Chilton 56-Year-Old Male With Ruptured Atherosclerotic Plaque Dr Schoenhagen/Dr Nissen

Educational Objectives:
Upon completion of this activity, the participant should be able to:

	Determine the point at which a patient with coronary artery disease should be managed with drug therapy after lifestyle modifications have been implemented
	Identify LDL-C goals for individual CAD patients according to both current recommendations and emerging data from major clinical trials
	Recognize the importance of diagnosing and treating outlying lesions in addition to the culprit lesion in a patient presenting with acute myocardial infarction
	Ascertain when a patient's treatment may need to extend beyond current guidelines and where to obtain proper guidance for such therapy and ongoing management

Intended Audience: primary care physicians, cardiologists, endocrinologists, physician assistants, nurse practitioners

*This activity is no longer valid for CME credit.

Faculty Disclosures:

Robert J. Chilton, DO
Has indicated no significant financial interests or relationships to disclose.

Paul Schoenhagen, MD
Has indicated no significant financial interests or relationships to disclose.

Steven E. Nissen, MD
Consultant or Research Study: Pfizer Inc; Merck & Co., Inc.; AstraZeneca; Sankyo Pharma Inc.; Takeda Pharmaceuticals North America, Inc.; Guidant; Aventis; Fournier; Boston Scientific; Pharmacyclics; Celltech; Esperion.